Researchers
We partner with researchers to develop their discoveries into therapeutics across a range of childhood cancers. Our goal is to progress these therapeutic assets into novel medicines for children and young people with cancer.
How we work with researchers
We provide a supportive pathway and resources to advance novel therapeutic assets. By joining us, you’ll gain access to state-of-the-art drug discovery facilities and expertise, and a collaborative network of passionate professionals.
What we're looking for
We are currently seeking proposals for novel therapeutic opportunities from organisations and researchers within the childhood cancer space across diverse modalities (small molecule, antibody-based, cell therapy and others). We are seeking proposals for therapeutic projects at the following or equivalent stages:
Hit identification
Hit validation
Hit-to-lead
Lead optimisation
We will support the enabling activities required at each stage. Watch our webinar for more details or contact us at EOI@c-further.org to book a 1:1 discussion.
How to work with us
We maintain a rolling call for collaborative projects, with review of expressions of interest happening every four months.
Expressions of interest for working with C-Further are invited for a first round of triage closing on November 1, 2024.
Information on subsequent deadlines for review will be published here.
By leveraging our industry-leading resources, world-renowned network of experts in drug discovery and development, and our tireless commitment to advancing impactful therapeutics, C-Further is extending the scope of innovation and investment in cancers affecting children and young people.
Heather McKinnon
Senior Director Translational Science, LifeArc
Have any questions?
Read through our frequently asked questions here and on our expressions of interest page. If you’re still not sure, watch our webinar for more details or contact us to book a 1:1 discussion.